Advanced search
Publication Cover
Acta Oncologica Volume 47, 2008 - Issue 6
Journal homepage
3,527
Views
40
CrossRef citations to date
0
Altmetric
Original Article

Δ9-Tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells

Gil Galanti The Mina and Everard Goodman Faculty of Life Science, Bar-Ilan University, Ramat-Gan, Israel; Department of Pediatric Hemato-Oncology, Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel
,
Tamar Fisher Department of Pediatric Hemato-Oncology, Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel
,
Iris Kventsel Department of Pediatric Hemato-Oncology, Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel
,
Jacob Shoham The Mina and Everard Goodman Faculty of Life Science, Bar-Ilan University, Ramat-Gan, Israel
,
Ruth Gallily The Lautenberg Center for General and Tumor Immunology, The Hebrew University Medical Faculty, Ein Kerem Campus, Jerusalem, Israel
,
Raphael Mechoulam Department of Medicinal Chemistry and Natural Products, Hebrew University Medical Faculty, Jerusalem, Israel
,
Gad Lavie Blood Center, Sheba Medical Center, Tel-Hashomer, Israel
,
Ninette Amariglio Department of Pediatric Hemato-Oncology, Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel
,
Gideon Rechavi Department of Pediatric Hemato-Oncology, Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel
&
Amos Toren Department of Pediatric Hemato-Oncology, Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, IsraelCorrespondence[email protected]
 show all
Pages 1062-1070 | Received 28 Jun 2007, Published online: 08 Jul 2009

Citations (40)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Rongheng Liao, Bo Xie, Jun Cui, Zhen Qi, Song Xue & Yongyi Wang. (2021) E2F transcription factor 1 (E2F1) promotes the transforming growth factor TGF-β1 induced human cardiac fibroblasts differentiation through promoting the transcription of CCNE2 gene. Bioengineered 12:1, pages 6869-6877.
Read now
Tim Hohmann, Urszula Grabiec, Chalid Ghadban, Kerstin Feese & Faramarz Dehghani. (2017) The influence of biomechanical properties and cannabinoids on tumor invasion. Cell Adhesion & Migration 11:1, pages 54-67.
Read now

Articles from other publishers (38)

Marc Richard Kolbe, Tim Hohmann, Urszula Hohmann, Erik Maronde, Ralph Golbik, Julian Prell, Jörg Illert, Christian Strauss & Faramarz Dehghani. (2023) Elucidation of GPR55-Associated Signaling behind THC and LPI Reducing Effects on Ki67-Immunoreactive Nuclei in Patient-Derived Glioblastoma Cells. Cells 12:22, pages 2646.
Crossref
Prateeksha Prateeksha, Vivek K. Sharma, Shiv M. Singh, Minaxi Sharma, Deepti Diwan, Abd El-Latif Hesham, Sanjay Guleria, Quang D. Nguyen, Vijai K. Gupta & Brahma N. Singh. (2023) Tetrahydrocannabinols: potential cannabimimetic agents for cancer therapy. Cancer and Metastasis Reviews 42:3, pages 823-845.
Crossref
Nurgul Carkaci-Salli, Wesley M. Raup-KonsavageDeepkamal KareliaDongxiao SunCheng JiangJunxuan Lu & Kent E. Vrana. (2023) Cannabinoids as Potential Cancer Therapeutics: The Concentration Conundrum. Cannabis and Cannabinoid Research.
Crossref
Sohaib Hourfane, Hicham Mechqoq, Abdellah Yassine Bekkali, João Miguel Rocha & Noureddine El Aouad. (2023) A Comprehensive Review on Cannabis sativa Ethnobotany, Phytochemistry, Molecular Docking and Biological Activities. Plants 12:6, pages 1245.
Crossref
J. Eduardo Rodriguez Almaraz & Nicholas Butowski. 2023. Cannabis Use, Neurobiology, Psychology, and Treatment. Cannabis Use, Neurobiology, Psychology, and Treatment 279 291 .
J. Eduardo Rodriguez-Almaraz & Nicholas Butowski. (2023) Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis). Current Treatment Options in Oncology 24:1, pages 30-44.
Crossref
Bianca Hanganu, Diana Elena Lazar, Irina Smaranda Manoilescu, Veronica Mocanu, Doina Butcovan, Camelia Liana Buhas, Andreea Silvana Szalontay & Beatrice Gabriela Ioan. (2022) Controversial Link between Cannabis and Anticancer Treatments—Where Are We and Where Are We Going? A Systematic Review of the Literature. Cancers 14:16, pages 4057.
Crossref
Agata Małek, Joanna Kocot, Kamila Mitrowska, Andrzej Posyniak & Jacek Kurzepa. (2022) Bee Venom Effect on Glioblastoma Cells Viability and Gelatinase Secretion. Frontiers in Neuroscience 16.
Crossref
Marta Iozzo, Giovanna Sgrignani, Giuseppina Comito, Paola Chiarugi & Elisa Giannoni. (2021) Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches. Cells 10:12, pages 3396.
Crossref
Zıad JOHA, Fatih YULAK, Ayşegül ÖZTÜRK, Bilal ŞAHİN & Şahin YILDIRIM. (2021) The Anticancer Effect of Cannabinoid 2 Agonist L-759,633 on C6 and SH-SY5Y Cell Lines. Turkish Journal of Science and Health.
Crossref
Bijo Mathew, Seetha Harilal, Arafa Musa, Rajesh Kumar, Della Grace Thomas Parambi, Jobin Jose, Md. Sahab Uddin, Muhammad Ajmal Shah, Tapan Behl & Mazhuvancherry Kesavan Unnikrishnan. (2021) An Agathokakological Tale of Δ9-THC: Exploration of Possible Biological Targets. Current Drug Targets 22:7, pages 823-834.
Crossref
Tamara T. Lah, Metka Novak, Milagros A. Pena Almidon, Oliviero Marinelli, Barbara Žvar Baškovič, Bernarda Majc, Mateja Mlinar, Roman Bošnjak, Barbara Breznik, Roby Zomer & Massimo Nabissi. (2021) Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma. Cells 10:2, pages 340.
Crossref
Wesley M. Raup-Konsavage, Nurgul Carkaci-Salli, Kelly Greenland, Robert Gearhart & Kent E. Vrana. (2020) Cannabidiol (CBD) Oil Does Not Display an Entourage Effect in Reducing Cancer Cell Viability in vitro. Medical Cannabis and Cannabinoids 3:2, pages 95-102.
Crossref
Erica L. Lyons, Sandra Leone-Kabler, Alexander L. Kovach, Brian F. Thomas & Allyn C. Howlett. (2020) Cannabinoid receptor subtype influence on neuritogenesis in human SH-SY5Y cells. Molecular and Cellular Neuroscience 109, pages 103566.
Crossref
Ana Laura Torres-Román, Victor Manuel García-Hernández, Edgar Rangel-López, Erika Ruiz-García, Abelardo Meneses-García, Abel Santamaría, Michael Aschner, Oscar Prospero-García & Alette Ortega-Gómez. (2020) Oleamide Induces Cell Death in Glioblastoma RG2 Cells by a Cannabinoid Receptor–Independent Mechanism. Neurotoxicity Research 38:4, pages 941-956.
Crossref
Recardia Schoeman, Natasha Beukes & Carminita Frost. (2020) Cannabinoid Combination Induces Cytoplasmic Vacuolation in MCF-7 Breast Cancer Cells. Molecules 25:20, pages 4682.
Crossref
Ângelo Luís, Helena Marcelino, Carolina Rosa, Fernanda Domingues, Luísa Pereira & José Francisco Cascalheira. (2020) The effects of cannabinoids on glioblastoma growth: A systematic review with meta-analysis of animal model studies. European Journal of Pharmacology 876, pages 173055.
Crossref
Vamsi Reddy, Dayton Grogan, Meenakshi Ahluwalia, Évila Lopes Salles, Pankaj Ahluwalia, Hesam Khodadadi, Katelyn Alverson, Andy Nguyen, Srikrishnan P. Raju, Pankaj Gaur, Molly Braun, Fernando L. Vale, Vincenzo Costigliola, Krishnan Dhandapani, Babak Baban & Kumar Vaibhav. (2020) Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies. EPMA Journal 11:2, pages 217-250.
Crossref
Chiara Laezza, Cristina Pagano, Giovanna Navarra, Olga Pastorino, Maria Chiara Proto, Donatella Fiore, Chiara Piscopo, Patrizia Gazzerro & Maurizio Bifulco. (2020) The Endocannabinoid System: A Target for Cancer Treatment. International Journal of Molecular Sciences 21:3, pages 747.
Crossref
Javad Sharifi-Rad, Adem Ozleyen, Tugba Boyunegmez Tumer, Charles Oluwaseun Adetunji, Nasreddine El Omari, Abdelaali Balahbib, Yasaman Taheri, Abdelhakim Bouyahya, Miquel Martorell, Natália Martins & William C. Cho. (2019) Natural Products and Synthetic Analogs as a Source of Antitumor Drugs. Biomolecules 9:11, pages 679.
Crossref
Liran Baram, Ella Peled, Paula Berman, Ben Yellin, Elazar Besser, Maya Benami, Igal Louria-Hayon, Gil M. Lewitus & David Meiri. (2019) The heterogeneity and complexity of Cannabis extracts as antitumor agents . Oncotarget 10:41, pages 4091-4106.
Crossref
Tim Hohmann, Kerstin Feese, Chalid Ghadban, Faramarz Dehghani & Urszula Grabiec. (2019) On the influence of cannabinoids on cell morphology and motility of glioblastoma cells. PLOS ONE 14:2, pages e0212037.
Crossref
Tim Hohmann, Kerstin Feese, Thomas Greither, Chalid Ghadban, Vivian Jäger, Faramarz Dehghani & Urszula Grabiec. (2019) Synthetic Cannabinoids Influence the Invasion of Glioblastoma Cell Lines in a Cell- and Receptor-Dependent Manner.. Cancers 11:2, pages 161.
Crossref
Claudia A. Dumitru, I. Erol Sandalcioglu & Meliha Karsak. (2018) Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs. Frontiers in Molecular Neuroscience 11.
Crossref
Hueng-Chuen Fan, Ching-Shiang Chi, Yu-Kang Chang, Min-Che Tung, Shinn-Zong Lin & Horng-Jyh Harn. (2018) The Molecular Mechanisms of Plant-Derived Compounds Targeting Brain Cancer. International Journal of Molecular Sciences 19:2, pages 395.
Crossref
Sanda Vladimir‐Knežević, Biljana Blažeković, Maja Bival Štefan & Marija Kindl. 2017. Natural Products and Cancer Drug Discovery. Natural Products and Cancer Drug Discovery.
Wei Chen, Xin-Ke Xu, Jun-Liang Li, Kuan-Kei Kong, Hui Li, Cheng Chen, Jing He, Fangyu Wang, Ping Li, Xiao-Song Ge & Fang-Cheng Li. (2017) MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression. Oncotarget 8:14, pages 22783-22799.
Crossref
Vilas Desai & Alok Bhushan. (2017) Natural Bioactive Compounds: Alternative Approach to the Treatment of Glioblastoma Multiforme. BioMed Research International 2017, pages 1-10.
Crossref
Yanan Li, Weijie Min, Mengmeng Li, Guosheng Han, Dongwei Dai, Lei Zhang, Xin Chen, Xinglai Wang, Yuhui Zhang, Zhijian Yue & Jianmin Liu. (2016) Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis. International Journal of Molecular Medicine 38:4, pages 1170-1178.
Crossref
Sureerat Buahorm, Songchan Puthong, Tanapat Palaga, Kriengsak Lirdprapamongkol, Preecha Phuwapraisirisan, Jisnuson Svasti & Chanpen Chanchao. (2015) Cardanol isolated from Thai Apis mellifera propolis induces cell cycle arrest and apoptosis of BT-474 breast cancer cells via p21 upregulation. DARU Journal of Pharmaceutical Sciences 23:1.
Crossref
Thangesweran Ayakannu, Anthony H. Taylor, Jonathan M. Willets & Justin C. Konje. (2015) The evolving role of the endocannabinoid system in gynaecological cancer. Human Reproduction Update 21:4, pages 517-535.
Crossref
Hye-Won Jung, Inae Park & Sungho Ghil. (2014) Cannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β. Cellular and Molecular Biology Letters 19:3.
Crossref
Francisco Carlos Machado Rocha, Jair Guilherme dos Santos Júnior, Sergio Carlos Stefano & Dartiu Xavier da Silveira. (2013) Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas. Journal of Neuro-Oncology 116:1, pages 11-24.
Crossref
Steven N. Gurley, Ammaar H. Abidi, Patrick Allison, Peihong Guan, Christopher Duntsch, Jon H. Robertson, Stanley D. Kosanke, Stephen T. Keir, Darell D. Bigner, Andrea J. Elberger & Bob M. MooreIIII. (2012) Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM-233. Journal of Neuro-Oncology 110:2, pages 163-177.
Crossref
Panagiotis J Vlachostergios, Ioannis A Voutsadakis & Christos N Papandreou. (2012) The ubiquitin-proteasome system in glioma cell cycle control. Cell Division 7:1, pages 18.
Crossref
Daniel J. Hermanson & Lawrence J. Marnett. (2011) Cannabinoids, endocannabinoids, and cancer. Cancer and Metastasis Reviews 30:3-4, pages 599-612.
Crossref
Jae Myung Park, Xiang-Shu Xian, Myung-Gyu Choi, Hyeyeon Park, Yu Kyung Cho, In Seok Lee, Sang Woo Kim & In-Sik Chung. (2011) Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells. Journal of Cellular Biochemistry 112:4, pages 1192-1205.
Crossref
Susanne Oesch & Jürg Gertsch. (2009) Cannabinoid receptor ligands as potential anticancer agents — high hopes for new therapies?. Journal of Pharmacy and Pharmacology 61:7, pages 839-853.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.